Domain
Lab results, specimens, LOINC codes and pathology
810 laboratory terms
The standardized alphanumeric identifier assigned to a hematology service, diagnosis, or procedure using coding systems such as CPT, ICD-10, or LOINC. Used across claims, laboratory, and clinical systems to uniquely identify blood study types, enable interoperability, and support consistent billing and clinical reporting.
The dollar amount a member owes as their percentage share of costs for hematology services, such as complete blood counts or bone marrow evaluations, after the deductible is met. Recorded on claims to calculate member cost-sharing obligations under their health plan.
Free-text notation entered by a clinician or lab technician to document supplemental observations, clarifications, or clinical context associated with a hematology test or blood study result that cannot be captured in structured data fields within the laboratory information system.
The calendar date on which a hematology procedure, such as a blood panel, bone marrow biopsy, or coagulation study, was fully completed and results were finalized. Used in laboratory and clinical systems to track turnaround time and close open orders.
A flag denoting that a hematology record contains sensitive patient information requiring restricted access, such as results related to HIV status or genetic blood disorders. Controls visibility and disclosure in clinical and administrative systems per privacy regulations.
The fixed out-of-pocket dollar amount a member is required to pay at the time hematology services are rendered, such as blood draws or specialist consultations for blood disorders. Captured on claims and remittance records to track member cost-sharing for plan benefit administration.
The numeric total of hematology events, tests, or records associated with a patient or encounter, such as the number of blood panels ordered during a treatment episode. Used in clinical reporting and population health analytics to measure utilization of hematology services.
The country in which a hematology service, blood study, or related clinical event was performed or where the ordering facility is located. Used in international patient records and cross-border claims processing to support geographic reporting and regulatory compliance.
The unique identifier of the user, clinician, or system that originally created the hematology record in the clinical or laboratory information system. Used in audit trails to establish accountability and support data governance for blood study documentation.
The calendar date on which a hematology record was first entered into the clinical, laboratory, or health information system. Used in audit logging, data lineage tracking, and workflow management to establish when a blood study order or result was initially documented.
The timestamp indicating the precise time of day a hematology record was first created in the laboratory or clinical information system. Combined with the created date to support full audit trail documentation, sequencing of lab orders, and result turnaround time analysis.
The measured serum or plasma creatinine value recorded as part of a hematology or comprehensive metabolic workup, used to assess kidney function in patients undergoing treatment for blood disorders. Elevated creatinine may influence dosing decisions for nephrotoxic hematologic therapies.
The calendar date associated with a hematology event, such as the date a blood test was ordered, collected, or resulted. Used in clinical workflows, laboratory information systems, and population health reporting to establish the timeline of blood study activity for a patient.
The combined date and time value marking a specific hematology event, such as specimen collection or result release, recorded in the laboratory or clinical information system. Enables precise sequencing of blood study activities and supports time-sensitive clinical decision-making.
The Drug Enforcement Administration registration number associated with a prescribing clinician who orders controlled substances as part of hematology treatment protocols, such as opioids for pain management in sickle cell disease. Used for regulatory compliance and controlled substance tracking.
The recorded date of death for a patient associated with a hematology record, used in longitudinal blood disorder tracking, clinical trial data, and mortality reporting for conditions such as leukemia or aplastic anemia. Supports outcomes analysis and registry reporting for hematologic diseases.
The dollar amount applied toward a member's annual deductible for hematology services, such as diagnostic blood panels or hematologic specialist visits, before the health plan begins covering costs. Captured on claims and remittance data to track member cost-sharing accumulation across the benefit year.
The calendar date on which a hematology record was marked as deleted or voided in the clinical or laboratory information system. Used in data governance, audit trails, and soft-delete workflows to preserve a record of when a blood study entry was removed without permanent data loss.
A flag indicating that a hematology record has been logically removed or voided from active use in the clinical or laboratory information system without being permanently purged. Used to exclude invalid or duplicate blood study records from reporting while preserving data history for audit purposes.
A human-readable text field providing the name or explanatory narrative of a hematology test, procedure, or blood disorder diagnosis. Used in clinical documentation, laboratory orders, and reporting interfaces to clearly identify the nature of a blood study for clinicians and administrative staff.